DCW47.08

DCW Limited

· Chemicals
AnnualQuarterly₹ CrorePeersMANALIPETCTNPETROAGARINDBEPLMcap ₹1,390 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations414.1397.8621.7499.5488.7474.2537.9475.5539.2519.8609.1541.9
Other Income4.44.45.66.46.04.85.94.04.64.85.65.7
Total Income418.4402.1627.2505.9494.7479.0543.8479.5543.8524.6614.7547.6
Expenses
+ Cost of Materials Consumed246.6274.8263.5290.2291.5262.8264.2260.1268.7264.1273.0335.4
+ Purchases of Stock-in-Trade0.00.02.510.66.31.00.20.20.30.20.00.0
+ Changes in Inventories-57.0-60.0104.8-36.7-32.9-25.055.7-19.825.033.268.7-23.6
+ Employee Benefit Expense37.335.337.345.341.742.831.345.743.140.952.341.2
+ Finance Costs18.518.019.916.918.416.215.815.115.516.215.414.8
+ Depreciation & Amortisation22.923.724.424.624.825.325.225.026.126.326.426.3
+ Other Expenses145.6128.4150.1144.9146.8135.6130.6135.5144.1136.2150.5153.1
Total Expenses414.0420.1602.6495.8496.5458.7523.1461.9522.8517.1586.3547.2
EBITDA41.619.463.445.235.457.055.953.758.045.264.635.8
EBIT18.6-4.339.020.610.631.730.628.732.018.938.29.5
Profit
PBT before Exceptional Items4.5-17.924.610.1-1.820.220.717.721.17.528.40.4
+ Exceptional Items0.0-1.1-0.00.00.00.00.00.00.00.00.00.0
Pretax Income4.5-19.024.610.1-1.820.220.717.721.17.528.40.4
+ Current Tax0.8-3.44.31.8-0.33.53.63.13.61.43.00.1
+ Deferred Tax1.0-3.34.91.6-0.23.35.73.23.61.37.2-34.3
Tax Expense1.8-6.79.23.4-0.56.89.46.37.22.610.3-34.2
Net Income2.7-12.315.36.7-1.213.411.411.413.84.918.134.5
+ Net Income — Continuing Ops2.7-12.315.36.7-1.213.411.411.413.84.918.134.5
+ Other Comprehensive Income0.00.0-0.20.00.00.0-0.60.00.00.0-0.30.0
Total Comprehensive Income2.7-12.315.16.7-1.213.410.811.413.84.917.834.5
Per Share
Basic EPS0.09-0.420.520.23-0.040.450.390.390.470.170.611.17
Diluted EPS0.09-0.420.520.23-0.040.450.390.390.470.170.611.17
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.60.00.00.0-0.30.0
+ Items NOT to be Reclassified to P&L-0.3-0.5
+ Tax on Items NOT to be Reclassified0.00.00.0-0.20.0
+ Tax on Items NOT to be Reclassified — alt tag-0.10.00.00.0
+ Items to be Reclassified to P&L-0.9
+ Tax on Items to be Reclassified-0.30.00.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations0.09-0.420.520.23-0.040.450.390.390.470.170.611.17
Diluted EPS — Continuing Operations0.09-0.420.520.23-0.040.450.390.390.470.170.611.17
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period13.76.331.9
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit224.5183.0250.9235.4223.9235.4217.8234.9245.2222.3267.4230.1
Gross Margin %54.2146.0140.3547.1245.8249.6440.4949.4045.4842.7743.9042.46
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)4.5-17.924.610.1-1.820.220.717.721.17.528.40.4
− Exceptional Items (reconciliation)0.0-1.1-0.00.00.00.00.00.00.00.00.00.0
Net Income Adj (tax-effected)2.7-11.615.46.7-1.213.411.411.413.84.918.134.5
EPS Adj0.09-0.400.520.23-0.040.450.390.390.470.170.611.17
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital59.059.059.059.059.059.059.059.059.059.059.059.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.